COMMUNIQUÉS West-GlobeNewswire
-
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
04/06/2026 -
CooperCompanies Announces Second Quarter 2026 Results
04/06/2026 -
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
04/06/2026 -
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
04/06/2026 -
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
04/06/2026 -
Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium
04/06/2026 -
Aja Health and Wellness Inc. Announces Agreement for the Sale of Assets of GOeVisit Service
05/06/2026 -
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
04/06/2026 -
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
04/06/2026 -
TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology
04/06/2026 -
Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz
04/06/2026 -
London Specialist Dentists Announce the Use of Ozone Therapy in Periodontal Treatment and Dental Implants
04/06/2026 -
MindBio Launches Intox AI™ in Major Advancement for Drug Use Detection
04/06/2026 -
Sienna Senior Living Inc. Announces Voting Results From Annual Meeting
04/06/2026 -
Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
04/06/2026 -
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
04/06/2026 -
NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances
04/06/2026 -
Adam Ferrari Health Science Scholarship Application Deadline Approaches for 2026 Cycle
04/06/2026 -
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
04/06/2026
Pages